Harbin Pharmaceutical Group Established the Big Health Research Institute

Recently, the inauguration ceremony of Harbin Pharmaceutical Group’s Big Health Research Institute was held in the R&D center of Hayao Sanchine. According to the introduction, with Fan Ning as the chief scientist, this “Big Health Research Institute” is composed of three different R&D blocks to create a domestic first-class innovative research system. As the leading enterprise in the bio-economy and pharmaceutical industry in the Heilongjiang Province, Harbin Pharmaceutical Group has achieved outstanding performance in ensuring drug supply and promoting public health. Therefore, as always, the Provincial Drug Administration will provide support for the development of HaPharm Group. (Source: 163.com)

Visit HPA-China’s Information Hub, CLICK HERE